HCM
DGX icon

Highbridge Capital Management’s Quest Diagnostics DGX Stock Holding History

Highbridge Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,600
Closed -$1.04M – 1552
2015
Q4 		$1.04M Buy
+14,600
New +$982K 0.02% 739
2015
Q2 		– Sell
-3,700
Closed -$284K – 1459
2015
Q1 		$284K Buy
+3,700
New +$265K ﹤0.01% 1150

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Highbridge Capital Management's DGX Position: Q1 2018 in Review

Highbridge Capital Management sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 116,169 shares — an estimated $11.4M sold.

Highbridge Capital Management first reported a position in DGX in Q4 2013 and held it in 4 quarters. The position peaked at $43.3M in Q4 2013. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • Highbridge Capital Management reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 116,169 Quest Diagnostics shares in Q1 2018, an estimated $11.4M.
  • Highbridge Capital Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 4 quarters.
  • Highbridge Capital Management's Quest Diagnostics position peaked at $43.3M in Q4 2013.
  • 652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.